Economic Atlas
Companies/Regeneron Pharmaceuticals, Inc.
Company profile

Regeneron Pharmaceuticals, Inc.

NASDAQ: REGN · Healthcare · Biotechnology
PublicHQ Tarrytown, NY · WestchesterCIK 0000872589Reports USD
#31 of 1,418 Healthcare companies by revenue44th-percentile growth
EA Score
85A
Revenue TTM
$14.9B
Rev growth YoY (TTM)
+5.9%
Net income (FY)
$4.5B
Employees
15,410
as of 2026-08-04
Market cap
$78.2B
as of 2026-08-04

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$14.3B$14.3B2025
Net income$4.5B$4.5B2025
Operating income$3.6B$3.6B2025
Total assets$40.6B$40.6B2025
Liabilities$9.3B$9.3B2025
Equity$31.3B$31.3B2025

Revenue trend

FY2020 – FY2025 · USD
FY20
FY20
FY20
FY21
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Collaboration Revenue51%
Product44%
Product and Service, Other5%
By geography
UNITED STATES90%
Rest Of World10%
The read

What is Regeneron Pharmaceuticals, Inc.’s revenue?

Regeneron Pharmaceuticals, Inc. booked $14.3B in FY2025 revenue, growing 1.0% year over year — about the middle of the pack among Healthcare companies we track, at a 31.4% net margin.

Peers · Healthcare
Boston Scientific Corporation88AUniversal Health Services, Inc.83B+IQVIA Holdings Inc.79B+Viatris Inc.63CLabcorp Holdings Inc.84B+DaVita Inc.77B+
Neighbors
Westchester →
International Business Machines Corporation$67.5B82B+Loar Holdings Inc.$496.3M51DPrestige Consumer Healthcare Inc.$1.1B78B+Sky Harbour Group Corp$27.5M44DNortheast Community Bancorp, Inc.——FRMO Corp.$263.4M——
Key facts
CEOLeonard S. Schleifer
SectorHealthcare
IndustryBiotechnology
HeadquartersTarrytown, NY
ExchangeNASDAQ: REGN
Employees15,410
IPO date1991-04-02
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.